Recent Advances on Pathophysiology, Diagnostic and Therapeutic Insights in Cardiac Dysfunction Induced by Antineoplastic Drugs

Table 1

Current insights in prevention, monitoring and treatment of cardiac dysfunction induced by anticancer drugs. Modified from [102].

Prevention	Monitoring	Treatment
Alternative anticancer strategies; Reduced chemotherapeutic dose; Liposomal formulations; Less toxic alternatives (epirubicin, lapatinib); Better patients selection; Age; Cardiac risk; Cardiac function; Use of cardioprotective drugs; β-blockers; ACE inhibitors; ARBs; Dexrazoxane; Statins	Imaging; Assess the best modality; Assess the best frequency; Biomarkers; BNP; Troponins; Novel markers (MPO?)	Hold or stop antineoplastic treatments; Start HF therapies